• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Italy·Industrials·GVS.MI
Share

GVS S.p.A. Stocks

€ 4.83Last Updated 25.08.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

€ 1.04B

€ 4.83
Key Takeaways

Risk factor

Weak & very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

GVS S.p.A., together with its subsidiaries, produces and sells filter solutions for applications in the healthcare and life sciences, energy and mobility, and health and safety sectors in Italy and internationally. The company offers health and safety products, such as hand dryer and vacuum cleaner filters; nailstation COSMO products; fume extraction and HVAC building products; and disposable masks, half masks, integra masks, powered air purifying respirators, face fit testing, replacement filters, supplied air respirators, spare parts, and accessories. It also provides autoclave filters, insufflation and ventilation filters and kits, machine filters, respiratory and anesthesia filters, smoke evacuation filters and kits, spirometry filters and accessories, suction filters, and tracheal humidifier filters; healthcare liquid products, such as bacterial air vents, blood tubular filters, infusion disc filters, IV and liquid filters, IV flow regulators, medical bags and components, sterile infusion sets and accessories, stopcock and manifold products, and transducer protectors; and capsule and cartridge filters, disc and sheet membranes, mini roll membranes, DNA/RNA test kits, filter papers, microbiology products, microfiltration devices, microporous and track etched roll membranes, protein microarrays, and environmental monitoring products, as well as western blotting membranes and reagents. In addition, the company offers energy and mobility products, such as fuel tanks and pumps, metal components, reservoirs, and SCR urea systems; ABS, ESP, and brake systems; EV applications and batteries; injection, tank vapour ventilation, and transmission products; ventilation systems; and cabin air and HVAC systems, and engine air intake ventilation filters. The company was formerly known as GVS S.r.l. and changed its name to GVS S.p.A. in 2001. GVS S.p.A. was founded in 1979 and is headquartered in Zola Predosa, Italy. GVS S.p.A. is a subsidiary of GVS Group S.r.l.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of GVS.MI is 5.48 and suggests 16.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.08.2026 21:50

Abercrombie shares posted their best single-day gain since 2025 following a strong earnings report

26.08.2026 21:27

Apple has announced the date for its fall event to unveil new devices

26.08.2026 20:40

At least 95 people have died, and hundreds are missing following floods in China and Nepal

26.08.2026 20:03

Microsoft, Amazon, and Google May Host a Chinese AI Model in Their Clouds — Media Reports

26.08.2026 19:32

Meta Will Pay Up to $16.7 Billion to Settle a Lawsuit Over the Harmful Effects of Social Media on Children

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026